Thymus Carcinoma — Trials

Thymus Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 10
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07750353	A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas(XANTHOS)	not yet recruiting	Phase 2	35	National Cancer Center, JapanOTHER_GOV	1	Aug 6, 2026	clinicaltrials
NCT07479628	Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma	not yet recruiting	Phase 2	31	Shanghai Chest HospitalOTHER	0	Mar 18, 2026